Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Topoisomerase Inhibitors | 2 | 2019 | 4 | 0.830 |
Why?
|
| DNA Topoisomerases, Type II | 5 | 2021 | 44 | 0.820 |
Why?
|
| DNA Topoisomerases, Type I | 2 | 2019 | 16 | 0.740 |
Why?
|
| DNA Cleavage | 1 | 2019 | 6 | 0.670 |
Why?
|
| DNA | 3 | 2019 | 1351 | 0.620 |
Why?
|
| Anti-Bacterial Agents | 3 | 2021 | 1477 | 0.520 |
Why?
|
| DNA Gyrase | 2 | 2021 | 12 | 0.350 |
Why?
|
| Topoisomerase II Inhibitors | 2 | 2021 | 23 | 0.350 |
Why?
|
| Schizosaccharomyces | 1 | 2009 | 53 | 0.320 |
Why?
|
| Telomere | 1 | 2009 | 202 | 0.290 |
Why?
|
| Piperazines | 2 | 2013 | 311 | 0.240 |
Why?
|
| DNA Replication | 3 | 2013 | 205 | 0.230 |
Why?
|
| Chromatin | 1 | 2005 | 428 | 0.200 |
Why?
|
| Replication Origin | 2 | 2013 | 15 | 0.190 |
Why?
|
| Chlorine | 1 | 2021 | 62 | 0.180 |
Why?
|
| Xenopus | 2 | 2013 | 98 | 0.170 |
Why?
|
| Fluoroquinolones | 1 | 2019 | 41 | 0.160 |
Why?
|
| Staphylococcus aureus | 2 | 2021 | 385 | 0.160 |
Why?
|
| Chromosomes | 2 | 2009 | 87 | 0.160 |
Why?
|
| Metals | 1 | 2019 | 107 | 0.160 |
Why?
|
| Catalytic Domain | 1 | 2019 | 197 | 0.160 |
Why?
|
| Quinazolinones | 1 | 2018 | 19 | 0.150 |
Why?
|
| Quinolones | 1 | 2019 | 97 | 0.150 |
Why?
|
| Pyrazines | 1 | 2018 | 71 | 0.150 |
Why?
|
| Imidazoles | 1 | 2018 | 211 | 0.140 |
Why?
|
| Protein Conformation | 1 | 2019 | 811 | 0.130 |
Why?
|
| Ovum | 2 | 2013 | 28 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2005 | 1895 | 0.120 |
Why?
|
| Models, Molecular | 1 | 2019 | 1378 | 0.120 |
Why?
|
| Replicon | 2 | 2013 | 14 | 0.110 |
Why?
|
| Spermatozoa | 3 | 2013 | 84 | 0.110 |
Why?
|
| S Phase | 2 | 2013 | 70 | 0.100 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 739 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2021 | 722 | 0.100 |
Why?
|
| Diketopiperazines | 2 | 2013 | 8 | 0.090 |
Why?
|
| Cell Nucleus | 3 | 2013 | 554 | 0.090 |
Why?
|
| Hep G2 Cells | 2 | 2021 | 61 | 0.080 |
Why?
|
| Dimerization | 1 | 2009 | 176 | 0.080 |
Why?
|
| Introns | 1 | 2009 | 227 | 0.080 |
Why?
|
| Point Mutation | 1 | 2009 | 216 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 345 | 0.080 |
Why?
|
| Catalysis | 1 | 2009 | 292 | 0.080 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2021 | 301 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 797 | 0.070 |
Why?
|
| Temperature | 1 | 2009 | 575 | 0.070 |
Why?
|
| Alleles | 1 | 2009 | 791 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1314 | 0.070 |
Why?
|
| Chromosome Structures | 1 | 2005 | 1 | 0.060 |
Why?
|
| Plasmids | 1 | 2005 | 345 | 0.060 |
Why?
|
| Nucleosomes | 1 | 2005 | 122 | 0.060 |
Why?
|
| Cell Cycle | 1 | 2005 | 543 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 751 | 0.050 |
Why?
|
| ERG1 Potassium Channel | 1 | 2021 | 4 | 0.050 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2021 | 31 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2021 | 74 | 0.050 |
Why?
|
| Alanine | 1 | 2021 | 104 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2021 | 101 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2021 | 89 | 0.040 |
Why?
|
| Drug Design | 1 | 2021 | 151 | 0.040 |
Why?
|
| Quinolines | 1 | 2021 | 129 | 0.040 |
Why?
|
| DNA, Single-Stranded | 1 | 2021 | 111 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 405 | 0.040 |
Why?
|
| Mutation | 1 | 2009 | 3349 | 0.040 |
Why?
|
| Models, Biological | 1 | 2005 | 1630 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2018 | 66 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 155 | 0.040 |
Why?
|
| Animals | 4 | 2018 | 31761 | 0.030 |
Why?
|
| Minichromosome Maintenance Complex Component 7 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Minichromosome Maintenance Complex Component 2 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Xenopus Proteins | 1 | 2013 | 56 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 85 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2013 | 153 | 0.030 |
Why?
|
| Male | 4 | 2018 | 55558 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 222 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 2118 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2013 | 696 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2008 | 15 | 0.020 |
Why?
|
| DNA, Ribosomal | 1 | 2008 | 79 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 2008 | 64 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2008 | 118 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 1550 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 6124 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 14916 | 0.010 |
Why?
|
| Humans | 2 | 2021 | 114716 | 0.010 |
Why?
|